Compare CABO & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CABO | HQL |
|---|---|---|
| Founded | 1980 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Investment Managers |
| Sector | Telecommunications | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 540.0M | 490.5M |
| IPO Year | 2015 | N/A |
| Metric | CABO | HQL |
|---|---|---|
| Price | $93.78 | $17.19 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $125.67 | N/A |
| AVG Volume (30 Days) | 96.2K | ★ 105.4K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $1,501,423,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.96 | N/A |
| P/E Ratio | ★ N/A | $21.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $70.37 | $11.58 |
| 52 Week High | $277.56 | $17.80 |
| Indicator | CABO | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 44.28 | 58.72 |
| Support Level | $87.53 | $16.40 |
| Resistance Level | $116.36 | $17.40 |
| Average True Range (ATR) | 5.81 | 0.35 |
| MACD | -0.23 | 0.11 |
| Stochastic Oscillator | 40.93 | 81.79 |
Cable One Inc is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. The company derives majority of its revenue from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.